Skip to main content

Table 2 Safety assessment based on treatment-emergent adverse event profiles (Intention to Treat)

From: Efficacy of bisphosphonate therapy on postmenopausal osteoporotic women with and without diabetes: a prospective trial

 

Non-DM (n = 63)

DM (n = 57)

Number of patients

5 (7.9%)

6 (10.5%)

Fever

1

0

Myalgia

2

3

Dyspepsia

1

1

Weight loss

1

2

  1. DM diabetes mellitus
Back to article page

BMC Endocrine Disorders

ISSN: 1472-6823

Contact us